{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T19:08:18Z","timestamp":1786993698923,"version":"build-2736575974"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T00:00:00Z","timestamp":1661731200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lungcancerjournal.info","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.lungcan.2022.08.020","type":"journal-article","created":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T00:06:12Z","timestamp":1662422772000},"page":"14-20","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Role of 18F-FDG PET\/CT in the postoperative follow-up in patients with stage I-III NSCLC: A retrospective single-institution study"],"prefix":"10.1016","volume":"173","author":[{"given":"Anna","family":"Kaumanns","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"K\u00f6nig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aljaz","family":"Hojski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Cattaneo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alin","family":"Chirindel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Wiese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Tamm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Didier","family":"Lardinois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sacha I.","family":"Rothschild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.lungcan.2022.08.020_b0005","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J Clin."},{"issue":"1","key":"10.1016\/j.lungcan.2022.08.020_b0010","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/S0022-5223(95)70427-2","article-title":"Incidence of local recurrence and second primary tumors in resected stage I lung cancer","volume":"109","author":"Martini","year":"1995","journal-title":"J. Thorac. Cardiovasc. Surg."},{"key":"10.1016\/j.lungcan.2022.08.020_b0015","doi-asserted-by":"crossref","unstructured":"al-Kattan K, Sepsas E, Fountain SW, Townsend ER. Disease recurrence after resection for stage I lung cancer. Eur. J. Cardiothorac Surg. 1997;12(3):380-4.","DOI":"10.1016\/S1010-7940(97)00198-X"},{"issue":"8","key":"10.1016\/j.lungcan.2022.08.020_b0020","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1200\/JCO.2002.08.092","article-title":"Long-term results of combined-modality therapy in resectable non-small-cell lung cancer","volume":"20","author":"Martin","year":"2002","journal-title":"J Clin Oncol."},{"issue":"2","key":"10.1016\/j.lungcan.2022.08.020_b0025","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.athoracsur.2006.08.046","article-title":"Survival after recurrent nonsmall-cell lung cancer after complete pulmonary resection","volume":"83","author":"Sugimura","year":"2007","journal-title":"Ann Thorac Surg."},{"issue":"4","key":"10.1016\/j.lungcan.2022.08.020_b0030","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/S0003-4975(00)01731-8","article-title":"Relevance of an intensive postoperative follow-up after surgery for non-small cell lung cancer","volume":"70","author":"Westeel","year":"2000","journal-title":"Ann Thorac Surg."},{"key":"10.1016\/j.lungcan.2022.08.020_b0035","doi-asserted-by":"crossref","unstructured":"Brierley JD, Gospodarowicz MK, Wittekind C. TNM Classification of Malignant Tumours, 8th edition: Wiley-Blackwell; 2016.","DOI":"10.1002\/9780471420194.tnmc26.pub3"},{"key":"10.1016\/j.lungcan.2022.08.020_b0040","doi-asserted-by":"crossref","unstructured":"Postmus PE, Kerr KM, Oudkerk M, Senan S, Waller DA, Vansteenkiste J, et al. Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2017;28 Suppl 4:iv1-iv21.","DOI":"10.1093\/annonc\/mdx222"},{"issue":"12","key":"10.1016\/j.lungcan.2022.08.020_b0045","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/j.annonc.2021.08.1994","article-title":"Early and locally advanced non-small-cell lung cancer: an update of the ESMO Clinical Practice Guidelines focusing on diagnosis, staging, systemic and local therapy","volume":"32","author":"Remon","year":"2021","journal-title":"Ann Oncol."},{"issue":"26","key":"10.1016\/j.lungcan.2022.08.020_b0050","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1200\/JCO.21.00276","article-title":"SAKK 16\/14: Durvalumab in Addition to Neoadjuvant Chemotherapy in Patients With Stage IIIA(N2) Non-Small-Cell Lung Cancer-A Multicenter Single-Arm Phase II Trial","volume":"39","author":"Rothschild","year":"2021","journal-title":"J Clin Oncol."},{"issue":"15_suppl","key":"10.1016\/j.lungcan.2022.08.020_b0055","doi-asserted-by":"crossref","first-page":"8503","DOI":"10.1200\/JCO.2021.39.15_suppl.8503","article-title":"Surgical outcomes from the phase 3 CheckMate 816 trial: Nivolumab (NIVO) + platinum-doublet chemotherapy (chemo) vs chemo alone as neoadjuvant treatment for patients with resectable non-small cell lung cancer (NSCLC)","volume":"39","author":"Spicer","year":"2021","journal-title":"J. Clin. Oncol."},{"issue":"10308","key":"10.1016\/j.lungcan.2022.08.020_b0060","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/S0140-6736(21)02098-5","article-title":"Adjuvant atezolizumab after adjuvant chemotherapy in resected stage IB-IIIA non-small-cell lung cancer (IMpower010): a randomised, multicentre, open-label, phase 3 trial","volume":"398","author":"Felip","year":"2021","journal-title":"Lancet"},{"issue":"18","key":"10.1016\/j.lungcan.2022.08.020_b0065","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1056\/NEJMoa2027071","article-title":"Osimertinib in Resected EGFR-Mutated Non-Small-Cell Lung Cancer","volume":"383","author":"Wu","year":"2020","journal-title":"N Engl J Med."},{"issue":"5 Suppl","key":"10.1016\/j.lungcan.2022.08.020_b0070","doi-asserted-by":"crossref","first-page":"e437S","DOI":"10.1378\/chest.12-2365","article-title":"Follow-up and surveillance of the patient with lung cancer after curative-intent therapy: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines","volume":"143","author":"Colt","year":"2013","journal-title":"Chest"},{"issue":"5","key":"10.1016\/j.lungcan.2022.08.020_b0075","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S1010-7940(00)00572-8","article-title":"Iterative surgical resections for local recurrent and second primary bronchogenic carcinoma","volume":"18","author":"Voltolini","year":"2000","journal-title":"Eur J Cardiothorac Surg."},{"issue":"3","key":"10.1016\/j.lungcan.2022.08.020_b0080","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1136\/thx.2007.094912","article-title":"Post-recurrence survival in completely resected stage I non-small cell lung cancer with local recurrence","volume":"64","author":"Hung","year":"2009","journal-title":"Thorax"},{"issue":"3","key":"10.1016\/j.lungcan.2022.08.020_b0085","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.jtcvs.2012.12.051","article-title":"Surgical treatment of metachronous second primary lung cancer after complete resection of non-small cell lung cancer","volume":"145","author":"Hamaji","year":"2013","journal-title":"J Thorac Cardiovasc Surg."},{"issue":"4","key":"10.1016\/j.lungcan.2022.08.020_b0090","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/0003-4975(91)91209-E","article-title":"Multiple primary lung carcinomas: prognosis and treatment","volume":"52","author":"Rosengart","year":"1991","journal-title":"Ann Thorac Surg."},{"issue":"5","key":"10.1016\/j.lungcan.2022.08.020_b0095","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1183\/09031936.00086712","article-title":"Relevance of an extensive follow-up after surgery for nonsmall cell lung cancer","volume":"42","author":"Gourcerol","year":"2013","journal-title":"Eur Respir J."},{"issue":"3","key":"10.1016\/j.lungcan.2022.08.020_b0100","doi-asserted-by":"crossref","first-page":"178S","DOI":"10.1378\/chest.07-1360","article-title":"Noninvasive Staging of Non-small Cell Lung Cancer","volume":"132","author":"Silvestri","year":"2007","journal-title":"Chest"},{"issue":"25","key":"10.1016\/j.lungcan.2022.08.020_b0105","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1056\/NEJMoa022136","article-title":"Staging of non-small-cell lung cancer with integrated positron-emission tomography and computed tomography","volume":"348","author":"Lardinois","year":"2003","journal-title":"N Engl J Med."},{"issue":"1","key":"10.1016\/j.lungcan.2022.08.020_b0110","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1056\/NEJMoa0900043","article-title":"Preoperative staging of lung cancer with combined PET-CT","volume":"361","author":"Fischer","year":"2009","journal-title":"N Engl J Med."},{"issue":"28","key":"10.1016\/j.lungcan.2022.08.020_b0115","doi-asserted-by":"crossref","first-page":"6846","DOI":"10.1200\/JCO.2005.10.116","article-title":"Etiology of solitary extrapulmonary positron emission tomography and computed tomography findings in patients with lung cancer","volume":"23","author":"Lardinois","year":"2005","journal-title":"J Clin Oncol."},{"issue":"10","key":"10.1016\/j.lungcan.2022.08.020_b0120","first-page":"1640","article-title":"PET\/CT using 18F-FDG in suspected lung cancer recurrence: diagnostic value and impact on patient management","volume":"45","author":"Keidar","year":"2004","journal-title":"J Nucl Med."},{"issue":"5","key":"10.1016\/j.lungcan.2022.08.020_b0125","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1093\/icvts\/ivs368","article-title":"18F-fluorodeoxyglucose positron emission tomography\/computed tomography is useful in postoperative follow-up of asymptomatic non-small-cell lung cancer patients","volume":"15","author":"Toba","year":"2012","journal-title":"Interact Cardiovasc Thorac Surg."},{"issue":"6","key":"10.1016\/j.lungcan.2022.08.020_b0130","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1016\/j.jtcvs.2009.09.055","article-title":"A follow-up of integrated positron emission tomography\/computed tomography after curative resection of non-small-cell lung cancer in asymptomatic patients","volume":"139","author":"Cho","year":"2010","journal-title":"J Thorac Cardiovasc Surg."},{"issue":"2","key":"10.1016\/j.lungcan.2022.08.020_b0135","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s11748-020-01477-1","article-title":"Diagnosis of recurrence and follow-up using FDG-PET\/CT for postoperative non-small-cell lung cancer patients","volume":"69","author":"Toba","year":"2021","journal-title":"Gen Thorac Cardiovasc Surg."},{"issue":"5","key":"10.1016\/j.lungcan.2022.08.020_b0140","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1016\/j.athoracsur.2011.07.005","article-title":"Positron emission tomography-computed tomography for postoperative surveillance in non-small cell lung cancer","volume":"92","author":"Choi","year":"2011","journal-title":"Ann Thorac Surg."},{"issue":"5","key":"10.1016\/j.lungcan.2022.08.020_b0145","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.ejcts.2006.08.008","article-title":"ESTS guidelines for intraoperative lymph node staging in non-small cell lung cancer","volume":"30","author":"Lardinois","year":"2006","journal-title":"Eur J Cardiothorac Surg."},{"issue":"6","key":"10.1016\/j.lungcan.2022.08.020_b0150","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1510\/icvts.2009.227538","article-title":"Clinical value of F18-fluorodeoxyglucose positron emission tomography-computed tomography in patients with non-small cell lung cancer after potentially curative surgery: experience with 241 patients","volume":"10","author":"Kanzaki","year":"2010","journal-title":"Interact Cardiovasc Thorac Surg."},{"issue":"2","key":"10.1016\/j.lungcan.2022.08.020_b0155","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.athoracsur.2018.08.015","article-title":"Comparing Two Imaging Methods for Follow-Up of Lung Cancer Treatment: A Randomized Pilot Study","volume":"107","author":"Gambazzi","year":"2019","journal-title":"Ann Thorac Surg."},{"issue":"10","key":"10.1016\/j.lungcan.2022.08.020_b0160","doi-asserted-by":"crossref","first-page":"e78552","DOI":"10.1371\/journal.pone.0078552","article-title":"Implications of false negative and false positive diagnosis in lymph node staging of NSCLC by means of (1)(8)F-FDG PET\/CT","volume":"8","author":"Li","year":"2013","journal-title":"PLoS ONE"},{"issue":"3","key":"10.1016\/j.lungcan.2022.08.020_b0165","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1177\/0284185113498536","article-title":"Diagnostic efficacy of PET and PET\/CT for recurrent lung cancer: a meta-analysis","volume":"55","author":"He","year":"2014","journal-title":"Acta Radiol."},{"issue":"7","key":"10.1016\/j.lungcan.2022.08.020_b0170","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.2967\/jnumed.111.099713","article-title":"Effect of PET\/CT on management of patients with non-small cell lung cancer: results of a prospective study with 5-year survival data","volume":"53","author":"Gregory","year":"2012","journal-title":"J Nucl Med."},{"issue":"6","key":"10.1016\/j.lungcan.2022.08.020_b0175","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1056\/NEJMoa1911793","article-title":"Reduced Lung-Cancer Mortality with Volume CT Screening in a Randomized Trial","volume":"382","author":"de Koning","year":"2020","journal-title":"N Engl J Med."},{"issue":"32","key":"10.1016\/j.lungcan.2022.08.020_b0180","doi-asserted-by":"crossref","first-page":"e1337","DOI":"10.1097\/MD.0000000000001337","article-title":"Recurrence Risk Factors Analysis for Stage I Non-small Cell Lung Cancer","volume":"94","author":"Wu","year":"2015","journal-title":"Medicine (Baltimore)."},{"issue":"4","key":"10.1016\/j.lungcan.2022.08.020_b0185","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1002\/cncr.29095","article-title":"Smoking history predicts for increased risk of second primary lung cancer: a comprehensive analysis","volume":"121","author":"Boyle","year":"2015","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.lungcan.2022.08.020_b0190","doi-asserted-by":"crossref","first-page":"e574","DOI":"10.1016\/j.cllc.2020.10.009","article-title":"Nomograms for Predicting Overall and Recurrence-free Survival From Pathologic Stage IA and IB Lung Cancer After Lobectomy","volume":"22","author":"Merritt","year":"2021","journal-title":"Clin Lung Cancer."},{"issue":"3","key":"10.1016\/j.lungcan.2022.08.020_b0195","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.lungcan.2004.08.011","article-title":"Prognostic value of smoking status in operated non-small cell lung cancer","volume":"47","author":"Sardari Nia","year":"2005","journal-title":"Lung Cancer."},{"issue":"5","key":"10.1016\/j.lungcan.2022.08.020_b0200","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.21037\/tlcr-20-505","article-title":"Prognostic implications of preoperative versus postoperative circulating tumor DNA in surgically resected lung cancer patients: a pilot study","volume":"9","author":"Ohara","year":"2020","journal-title":"Transl Lung Cancer Res."},{"key":"10.1016\/j.lungcan.2022.08.020_b0205","doi-asserted-by":"crossref","unstructured":"Xia L, Mei J, Kang R, Deng S, Chen Y, Yang Y, et al. Perioperative ctDNA-based Molecular Residual Disease Detection for Non-Small Cell Lung Cancer: A Prospective Multicenter Cohort Study (LUNGCA-1). Clin Cancer Res. 2021.","DOI":"10.1158\/1078-0432.CCR-21-3044"},{"issue":"2","key":"10.1016\/j.lungcan.2022.08.020_b0210","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1002\/1878-0261.13116","article-title":"Early assessment of circulating tumor DNA after curative-intent resection predicts tumor recurrence in early-stage and locally advanced non-small-cell lung cancer","volume":"16","author":"Waldeck","year":"2022","journal-title":"Mol Oncol"},{"issue":"2","key":"10.1016\/j.lungcan.2022.08.020_b0215","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.1016\/j.cllc.2019.11.002","article-title":"Surveillance With PET\/CT and Liquid Biopsies of Stage I-III Lung Cancer Patients After Completion of Definitive Therapy: A Randomized Controlled Trial (SUPER)","volume":"21","author":"Skougaard","year":"2020","journal-title":"Clin Lung Cancer."}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500222006109?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0169500222006109?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T13:00:55Z","timestamp":1759237255000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0169500222006109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":43,"alternative-id":["S0169500222006109"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2022.08.020","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of 18F-FDG PET\/CT in the postoperative follow-up in patients with stage I-III NSCLC: A retrospective single-institution study","name":"articletitle","label":"Article Title"},{"value":"Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lungcan.2022.08.020","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}